Related Experiment Video

Updated: Mar 10, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.3K

A Review of Hypertension Management in Atrial Fibrillation

Sidakpal S Panaich, Nilay Patel, Kanishk Agnihotri

  • 1The Everett Clinic, 3901 Hoyt Ave, Everett, WA 98201, United States.

Current Hypertension Reviews
|December 15, 2016
PubMed

Insights

Hypertension significantly increases the risk of developing atrial fibrillation (AF) and stroke. Managing blood pressure in AF patients requires careful consideration to avoid adverse outcomes, especially with strict control.

Area of Science:

  • Cardiology
  • Hypertension Management
  • Arrhythmia Research

Background:

  • Atrial fibrillation (AF) is a common arrhythmia with significant healthcare and economic impact, projected to double by 2050.
  • Hypertension is a major risk factor for developing AF and increases stroke risk in AF patients.
  • Existing guidelines lack specific blood pressure targets for AF patients.

Purpose of the Study:

  • To review current literature on managing hypertension in patients with atrial fibrillation.
  • To explore the role of antihypertensive medications in reducing AF incidence.
  • To discuss the complexities of blood pressure control in AF.

Main Methods:

  • Literature review of existing studies on hypertension and AF.
  • Analysis of randomized trials on blood pressure reduction and cardiovascular outcomes.
  • Examination of data on "J-shaped" or "U-shaped" curves in AF patient blood pressure management.

Main Results:

  • Antihypertensive medications may reverse structural and functional changes associated with AF.
  • Blood pressure reduction in general populations reduces stroke and heart failure risk.
  • Data suggests potential worse outcomes with strict blood pressure control (<110/60 mmHg) in AF patients.

Conclusions:

  • Optimal blood pressure management in AF patients is complex and requires further investigation.
  • Individual antihypertensive agents may play a role in AF prevention and management.
  • Current guidelines need to address specific blood pressure goals for patients with AF.

Keywords:
ACE Inhibitors/ARBsAtrial Fibrillationantihypertensive medicationsbeta blockersdiureticshypertensionmanagement

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.7K
Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

2.2K

Related Concept Videos

Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
584
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
800
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
529
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
541
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
453
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
554